Omnicell (OMCL) Tops Q1 EPS by 22c ; Offers Guidance

Go back to Omnicell (OMCL) Tops Q1 EPS by 22c ; Offers Guidance

Omnicell (OMCL) PT Lowered to $55 at Piper Sandler

April 28, 2026 2:02 PM EDT

Piper Sandler analyst Jessica Tassan lowered the price target on Omnicell (NASDAQ: OMCL) to $55.00 (from $57.00) while maintaining a Overweight rating.

The analyst comments "OMCL reported a 42.2% 1Q26 adjusted EBITDA beat and raised CY26 earnings guidance. We recap the numbers and the guide below. Callback notes on page 4. Reiterate OW. PT to $55 (prior $57) on an unchanged 15x multiple of more temperate CY27E adjusted EBITDA. The numbers. 1Q26 Products Revenue of $174.8M exceeded the midpoint of guidance/ consensus at $173.5M/ $172.9M. 1Q26 Services Revenue of $135.1M exceeded the midpoint of guidance/ consensus at... More